These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39379100)

  • 1. MIAT promotes myofibroblastic activities and transformation in oral submucous fibrosis through sponging the miR-342-3p/SOX6 axis.
    Lu MY; Fang CY; Hsieh PL; Chao SC; Liao YW; Ohiro Y; Yu CC; Ho DC
    Aging (Albany NY); 2024 Oct; 16(19):12909-12927. PubMed ID: 39379100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
    Yu CC; Liao YW; Hsieh PL; Chang YC
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
    Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
    J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
    Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
    J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
    Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
    J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
    Huang J; Zhang H; Fan X; Guo J
    Oral Health Prev Dent; 2022 Aug; 20():339-348. PubMed ID: 35920886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
    Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
    J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.
    Lin CY; Liao YW; Hsieh PL; Lu MY; Peng CY; Chu PM; Yang HW; Huang YF; Yu CC; Yu CH
    J Formos Med Assoc; 2018 Aug; 117(8):727-733. PubMed ID: 29249416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosis.
    Yu CC; Hsieh PL; Chao SC; Liao YW; Yu CH; Chueh PJ; Peng CY; Lee SS
    J Cell Mol Med; 2024 Sep; 28(18):e70112. PubMed ID: 39320020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
    Yu CC; Tsai CH; Hsu HI; Chang YC
    PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis.
    Lee YH; Liao YW; Lu MY; Hsieh PL; Yu CC
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
    Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
    Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
    Shieh DH; Chiang LC; Shieh TY
    Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.
    Bin X; Cheng JY; Deng ZY; Li B; Xu XH; Liu OS; Tang Z
    J Oral Pathol Med; 2024 Aug; 53(7):468-479. PubMed ID: 38802299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
    Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
    J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
    Yu CC; Liao YW; Yu CH; Chang YC
    J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
    Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
    J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.